Rossari Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/04/2026 ,inter alia, to consider and approve 1. Audited Financial Statements ....
ROSSARI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Rossari Biotech has informed exchanges that its Board of Directors will meet on Monday, April 27, 2026. The key agenda items are: (1) approval of the Audited Financial Statements and Financial Results (both Standalone and Consolidated) for Q4 and the full financial year ended March 31, 2026, and (2) recommendation of a Final Dividend, if any, for FY26. The trading window for designated persons and their immediate relatives remains closed from April 1, 2026 until 48 hours after the audited results are announced. No actual financial numbers or dividend amount have been disclosed yet — they will come after the Board meeting.
This is a routine pre-results intimation with no new financial information. Shareholders should watch the April 27 announcement for actual FY26 earnings and any dividend declaration, which could influence short-term stock sentiment.